Summary
Enteric-coated formulations of acetylsalicylic acid (ASA) should be advantageous in prophylaxis after stroke because they cause fewer gastrointestinal side effects. However, the absorption of unchanged ASA and the effectiveness of these formulations have been questioned, which prompted the present investigation. Fourteen elderly stroke patients on long-term medication with enteric-coated ASA 1.5 g daily and four patients on placebo were studied. When tested with arachidonic acid platelet aggregation was completely inhibited in all ASA subjects whereas it was normal in the controls. Plasma samples, drawn every 1/2 h for 6 h after tablet intake, were analyzed by HPLC. The presence of ASA was short lasting with a mean peak concentration of 55 µmol/l reached after 2–3.5 h. Salicylic acid (SA) appeared later, having a mean peak value of 591 µmol/l after 2.5–6 h. Thus, absorption of ASA as well as inhibition of platelet aggregation were confirmed during long-term medication with enteric-coated ASA.
References
Brantmark B, Wåhlin-Boll E, Melander A (1982) Bioavailability of acetylsalicylic acid and salicylic acid from rapid and slow-release formulations, and in combination with dipyridamole. Eur J Clin Pharmacol 22: 309–314
Ross-Lee LM, Elms MJ, Cham BE, Bochner F, Bunce IH, Eadie MJ (1982) Plasma levels of aspirin following effervescent and enteric coated tablets and their effect on platelet function. Eur J Clin Pharmacol 23: 545–551
Ali M, McDonald JWD, Thiessen JJ, Coates PE (1980) Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. Stroke 11: 9–13
Svensson J, Mettinger KL, Blombäck M (1983) Enteric-coated aspirin and cyclooxygenase inhibition. Thromb Res 29: 99–102
Wåhlin-Boll E, Brantmark B, Hanson A, Melander A, Nilsson C (1981) High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin and indobufen. Eur J Clin Pharmacol 20: 375–378
Mason WD, Winer N (1981) Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions. J Pharm Sci 70: 262–265
Koch PA, Schultz CA, Wills RJ, Hallquist SL, Welling PG (1978) Influence of food and fluid ingestion on aspirin bioavailability. J Pharm Sci 67: 1533–1535
Biggs DF, Coutts RT, Walter LJ (1977) A note on the bioavailability of five Canadian brands of acetylsalicylic acid tablets. Can J Pharm Sci 12: 23–25
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Britton, M., Melander, A., Svensson, J. et al. Platelet aggregation and plasma levels of acetylsalicylic acid in stroke patients on long-term treatment with an enteric-coated aspirin formulation. Eur J Clin Pharmacol 27, 363–365 (1984). https://doi.org/10.1007/BF00542177
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542177